Pre-op Testing Guidelines
A guideline is an evidence-based recommendation to assist clinical decision-making — not a rule, but a framework that supports professional judgement.
Based on NICE NG45, 2022 ESC/ESAIC & 2024 AHA/ACC Guidelines
Note — Age & Preoperative Testing:
- NICE NG45: Age alone does not trigger preoperative testing.
- ESC 2022: Age ≥65 is an independent cardiovascular risk factor that qualifies patients for biomarker testing (troponin — Class I, BNP — Class IIa) before intermediate or high-risk surgery, and lowers the threshold for cardiac investigations, particularly when combined with limited functional capacity.
- AHA/ACC 2024: Age is incorporated into the NSQIP surgical risk calculator rather than listed as a standalone trigger (RCRI does not include age).
Step 2 — ASA Physical Status
ASA 1
Healthy — no systemic disease
- No comorbidities
- Non-smoker, BMI <30
ASA 2
Mild disease — no functional limit
- Current smoker
- Social drinker
- Pregnancy
- Obesity (BMI 30–40)
- Well-controlled DM (NIDDM)
- Well-controlled HTN
- Mild asthma / lung disease
- Controlled epilepsy
- Controlled dysrhythmias
- Asymptomatic congenital cardiac
- Well-controlled GORD
ASA 3
Severe disease — functional limit
- Poorly controlled DM/HTN
- COPD
- Morbid obesity (BMI >40)
- Hepatitis / alcohol dependence
- Pacemaker / ICD
- Reduced ejection fraction
- Hx MI/stents/CABG (>3mo)
- Hx CVA/TIA (>3mo)
- Dialysis
ASA 4 — Constant threat to life:
Recent (<3mo) MI/CVA/stents | Ongoing ischaemia | Severe valve disease | Severely reduced EF | Sepsis
Step 3 — Which Tests to Order (NICE NG45)
Yes = offer test | Consider = if clinically indicated | — = not routinely
Minor Surgery
| Test | ASA 1 | ASA 2 | ASA 3–4 |
| FBC | — | — | — |
| Kidney | — | — | Consider |
| Haemostasis | — | — | — |
| ECG | — | — | Consider* |
| Lung Fn / ABG | — | — | — |
| Troponin (ESC/AHA) | — | — | — |
| BNP (ESC/AHA) | — | — | — |
Intermediate Surgery
| Test | ASA 1 | ASA 2 | ASA 3–4 |
| FBC | — | — | Consider |
| Kidney | — | Consider | Yes |
| Haemostasis | — | — | Consider |
| ECG | — | Consider* | Yes |
| Lung Fn / ABG | — | — | Consider |
| Troponin (ESC/AHA) | — | Consider | Yes |
| BNP (ESC/AHA) | — | Consider | Yes |
Major / Complex Surgery
| Test | ASA 1 | ASA 2 | ASA 3–4 |
| FBC | Yes | Yes | Yes |
| Kidney | Consider | Yes | Yes |
| Haemostasis | — | — | Consider |
| ECG | Consider* (>65) | Yes | Yes |
| Lung Fn / ABG | — | — | Consider |
| Troponin (ESC/AHA) | Consider (>65) | Yes | Yes |
| BNP (ESC/AHA) | Consider (>65) | Yes | Yes |
* No recent ECG in hospital records (last 6–12 months) → ECG Yes.
Step 4 — Cardiac Investigations (AHA/ACC 2024)
Stepwise Cardiac Assessment
- Surgery urgency? Emergency (<2hr), Urgent (2–24hr), Time-sensitive (<3mo), Elective
- Unstable cardiac condition? ACS, decompensated HF, unstable arrhythmia → defer elective surgery
- Estimate MACE risk: Low (<1%) → proceed. Elevated (≥1%) → continue
- Risk modifiers? Severe valvular disease, pulmonary HTN, prior PCI/CABG, recent stroke, cardiac devices, frailty
- Functional capacity: Can they climb 2 flights of stairs? (≥4 METs) → low risk, proceed
- Poor capacity + elevated risk → biomarkers, then stress test if it changes management
Troponin
- Pre-op: Consider if elevated risk + poor exercise capacity
- Post-op: Consider at 24 + 48hr in high-risk patients
BNP / NT-proBNP
- Consider if elevated risk + poor exercise capacity
- Normal (BNP <92, NT-proBNP <300) → no further cardiac tests
Echocardiography
- New dyspnoea / worsening symptoms
- Suspected mod-severe valvular disease
- Not routine if stable + echo <1yr
Stress Testing
- Only if result changes management
- Not indicated if low risk or ≥4 METs
- CT coronary angio is an alternative
Functional Capacity — Quick Guide
≥4 METs (good) → Proceed
- Climb 2 flights of stairs
- Walk up a hill
- Walk at 6 km/h on flat
- Heavy housework
<4 METs (poor) → Assess further
- Cannot climb 1 flight
- Short distances only on flat
- Light housework only
- → Biomarkers → stress test